Pharmacology: Heme/Onc Flashcards
Heparin
What lab value do you monitor?
Anti-coagulant; binds and enhances anti-thrombin III activity (induces conformational change that allows ATIII to rapidly inhibit thrombin [IIa], Xa, IXa, VIIa)
- Rapid effect
- Does not work on thrombin already bound to fibrin
- Monitor PTT
SE: excessive bleeding, HIT, osteoporosis, hypersensitivity, use low doses to decr risk from thrombosis from reduced levels of ATIII
Protamine sulfate
Reverses heparin action
- positively charged drug that binds negatively charged heparin
Enoxaparin
Monitor labs?
Anticoagulant; LMWH
- More Xa effects
- No labs to monitor
Lepirudin
Anticoagulant; direct thrombin inhibitor
Alternative for anticoaguation in HIT
Bivalirudin
Anticoagulant; direct thrombin inhibitor
Alternative for anticoaguation in HIT
Warfarin (Coumadin)
Anticoagulant; inhibits epoxide reductase (gamma-carboxylation of Vit K dependent clotting factors)
- Cyt P450 metabolism
- Long half-life
SEs: bleeding, teratogenic, drug-drug reactions, skin/tissue necrosis! (From pro-thrombotic state when anti-coag PC/PS initially decreases before clotting factors)
Fondaparinux
Synthetic pentasaccharide, selective Factor Xa inhibitor (NOT thrombin)
Streptokinase
Thrombolytic
Complexes with plasminogen and the resulting complex activates plasminogen to plasmin conversion
- Early MI, early ischemic stroke
SEs: Bleeding! (Don’t use in active bleeding, ICH, recent surgery, bleeding d/o, severe hypertension
Urokinase
Thrombolytic
Directly activates plasminogen to plasmin
tPA
Thrombolytic
Directly activates plasminogen to plasmin
Alteplase
Another name for tPA!
Thrombolytic
Directly activates plasminogen to plasmin
Anisoylated plasminogen streptokinase activator complex (APSAC)
Thrombolytic, already activated complex
Aminocaproic acid
Inhibits fibrinolysis by preventing plasminogen activation
SE: intravascular thrombosis
Tranexamic acid
Inhibits fibrinolysis by preventing plasminogen activation
SE: intravascular thrombosis
Aspirin
What does the BT, PT, PTT look like?
Anti-platelet (low dose), anti-pyretic and analgesic (med dose), anti-inflammatory (high dose)
- Acetylates and irreversibly inhibits COX-1 and -2
- Prevents AA –> TXA2 conversion (which normally mediates plt aggregation) and AA –> PGs
- Increases BT
- No effect on PT/PTT
SEs:
- GI: gastric ulcers, bleeding
- Renal: RF, AIN
- Hyperventilation, tinnitus (CN VIII)
- Reye’s syndrome in kids (rash, encephalitis, fatty liver)
Clopidogrel
Anti-platelet
Irreversible blockade of ADP receptors, prevent gpIIb/IIIa expression decr fibrinogen binding
Ticlopidine
Anti-platelet
Irreversible blockade of ADP receptors, prevent gpIIb/IIIa expression decr fibrinogen binding
SE: Neutropenia!
Clopidogrel vs. ticlopidine
Ticlopidine can cause neutropenia
Cilostazol
PDE III inhibitor (which normally degrade cAMP), increases cAMP and prevents platelet aggregation
Uses: intermittent claudication, coronary vasodilation, prevent stroke/TIA with ASA, ppx angina
SEs: nausea, HA, facial flushing, hypotension,abdominal pain
Dipyridamole
PDE III inhibitor (which normally degrade cAMP), increases cAMP and prevents platelet aggregation
Uses: same as cilostazol, also used in pharmacologic stress testing
Abiciximab
Antiplatelet
Monoclonal antibody against gp IIb/IIIa on activated platelets
Eptifibaride
Antiplatelet
Peptide inhibitor of gp IIb/IIIa
Tirofiban
Antiplatelet
Non-peptide inhibitor of gp IIb/IIIa
Hirudin
Direct thrombin inibitor